Exercise-Induced Kidney Blood Flow Response in African American Adults
Trial Summary
What is the purpose of this trial?
African American (AA) adults have a greater prevalence of developing cardiovascular and renal disease (CVRD) than White (W) adults. Elevated sympathetic nervous system activity is associated with increased incidence of CVRD. Physical exertion, such as exercise, acutely increases sympathetic nervous system activity directed towards the kidneys, resulting in renal vasoconstriction and reduced renal blood flow (RBF). However, the acute renal vasoconstrictor response to any sympathetic nervous system activation has not been investigated to date in AA adults. During sympathetic nervous system activation such as exercise, sympathetic outflow to the kidneys in AA adults might be exaggerated, contributing to greater renal vasoconstriction and a larger reduction in RBF. Over time, this exaggerated neurovascular response to sympathetic activation could have a negative cumulative effect on the kidneys, which could be a contributing factor to the greater incidence of CVRD in this population. Therefore, this study aims to examine the renal vasoconstrictor response to sympathetic stressors in healthy AA adults prior to development of CVRD to test the hypotheses that the renal vasoconstrictor response to acute dynamic exercise, as well as a cold pressor and mental stress tests, is exaggerated in healthy young AA compared to W adults. To test these hypotheses, the investigators will measure RBF and blood pressure at rest and during cycling exercise and a cold pressor and mental stress tests to calculate renal vascular resistance responses to these acute interventions. Using the highly innovative approach of Doppler ultrasound to measure RBF during exercise and non-exercise sympathetic stressors non-invasively and with high temporal resolution will enable us to assess the renal vasoconstrictor response to sympathetic stressors in healthy AA adults prior to development of CVRD, so the underlying integrative physiological responses to sympathetic activation in AA adults can be understood. Findings from this study in this understudied yet clinically significant area will contribute to the ultimate goal of creating and implementing treatment strategies to reduce the risk of developing CVRD in AA adults.
Do I need to stop my current medications for the trial?
Yes, you will need to stop taking any prescribed cardiovascular, antihypertensive, or renal medications to participate in this trial.
What data supports the effectiveness of the treatment involving exercise and cold pressor tests in African American adults?
Research shows that regular aerobic exercise can reduce the exaggerated blood pressure response to cold stress in African Americans, which may help prevent high blood pressure. Studies found that physically active individuals had better cardiovascular responses during cold stress tests compared to inactive ones.12345
Is exercise-induced kidney blood flow response safe for African American adults?
The studies suggest that physical activities like aerobic exercise and cold pressor tests are generally safe for African American adults, as they have been used to study blood pressure responses without reported safety issues. However, these activities can cause temporary changes in blood pressure and heart rate, which are normal responses to stress and exercise.23567
How does the treatment of exercise-induced kidney blood flow response differ from other treatments?
This treatment is unique because it combines physical activity, cold exposure, and mental stress to study their effects on kidney blood flow, particularly in African American adults. Unlike standard drug treatments, this approach uses natural stimuli to understand physiological responses, which may provide insights into managing conditions like hypertension (high blood pressure) without medication.238910
Research Team
Rachel C Drew, PhD
Principal Investigator
University of Massachusetts, Boston
Eligibility Criteria
This trial is for African American and White adults born in the U.S., fluent in English, who are active but not training competitively. Participants must have parents of the same racial identity. It excludes pregnant or lactating women, those with hypertension, diabetes, obesity, smokers, or anyone with cardiovascular/renal disease.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Exercise Intervention
Participants undergo acute dynamic exercise to measure renal blood flow and blood pressure responses
Cold Pressor and Mental Stress Tests
Participants undergo cold pressor and mental stress tests to measure renal vascular resistance and other cardiovascular responses
Follow-up
Participants are monitored for safety and effectiveness after interventions
Treatment Details
Interventions
- Acute exercise
- Cold pressor test
- Mental stress test
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Massachusetts, Boston
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator